(-)-Δ9-THC-D3
1.0 mg/mL in Methanol
|
T-011
|
|
|
Lorazepam glucuronide
100 ug/mL in 50:50 Acetonitrile:Water
|
L-021
|
|
|
(±)-MDEA-D6 [(±)-3,4-Methylenedioxyethylamphetamine-D6]
1.0 mg/mL in Methanol
|
M-082
|
|
|
Mephedrone HCl
1.0 mg/mL (as free base) in Methanol
|
M-138
|
|
|
1-(3-Chlorophenyl)piperazine (mCPP) HCl
1.0 mg/mL (as free base) in Methanol
|
C-089
|
|
|
Mephedrone-D3 HCl
100 ug/mL (as free base) in Methanol
|
M-139
|
|
|
10-Oxomorphine (10-Ketomorphine)
100 ug/mL in Methanol
|
IMPM-005-06
|
|
|
Metaxalone
1.0 mg/mL in Methanol
|
M-074
|
|
|
17α-Hydroxyprogesterone
1.0 mg/mL in Methanol
|
H-085
|
|
|
Methyl-D3-malonic acid
1.0 mg/mL in Acetonitrile
|
M-105
|
|
|
17β-Estradiol
1.0 mg/mL in Acetonitrile
|
E-060
|
|
|
Modafinil
1.0 mg/mL in Acetonitrile
|
M-084
|
|
|
17β-Estradiol-D5
100 ug/mL in Acetonitrile
|
E-061
|
|
|
Morphine-6-β-D-glucuronide
1.0 mg/mL in Water:Methanol (80:20)
|
M-046
|
|
|
2-Hydroxyethylflurazepam-D4
1.0 mg/mL in Methanol
|
H-923
|
|
|
Mycophenolic acid
1.0 mg/mL in Acetonitrile
|
M-106
|
|
|
25-Hydroxyvitamin D2
5 ug/mL in Ethanol
|
H-087
|
|
|
Mycophenolic acid-β-D-glucuronide
1.0 mg/mL in Acetonitrile
|
M-135
|
|
|
25-Hydroxyvitamin D2
50 ug/mL in Ethanol
|
H-073
|
|
|
N-Desethylamiodarone HCl
1.0 mg/mL (as free base) in Methanol
|
D-055
|
|
|
25-Hydroxyvitamin D3
5 ug/mL in Ethanol
|
H-086
|
|
|
N-Desmethylclobazam
100 ug/mL in Acetonitrile
|
D-049
|
|
|
25-Hydroxyvitamin D3
100 ug/mL in Ethanol
|
H-083
|
|
|
N-Desmethylclozapine
1.0 mg/mL in Methanol
|
D-048
|
|
|
4-Hydroxymephenytoin
100 ug/mL in Methanol
|
H-077
|
|
|
N-Desmethyltapentadol
1.0 mg/mL in Methanol
|
D-052
|
|
|
7-Aminoflunitrazepam-D7
1.0 mg/mL in Acetonitrile
|
A-925
|
|
|
Noratropine HCl
1.0 mg/mL (as free base) in Methanol
|
N-057
|
|
|
7-Hydroxyquetiapine
1.0 mg/mL in Methanol
|
H-081
|
|
|
Norbuprenorphine-D3
1.0 mg/mL in Methanol
|
N-921
|
|
|
9-Hydroxyrisperidone
1.0 mg/mL in Methanol
|
H-076
|
|
|
Norcocaine-D3 HCl
100 ug/mL (as free base) in Acetonitrile
|
N-034
|
|
|
α-Hydroxytriazolam-D4
1.0 mg/mL in Methanol
|
T-916
|
|
|
Norfentanyl-D5 oxalate
1.0 mg/mL (as free base) in Methanol
|
N-055
|
|
|
Amiodarone HCl
1.0 mg/mL (as free base) in Methanol
|
A-060
|
|
|
Octafluoronaphthalene EI Scan Qualification Standard for GC/MS
1.0 pg/uL in Iso-Octane
|
OQ-001
|
|
|
Aripiprazole
1.0 mg/mL in Acetonitrile
|
A-080
|
|
|
Orlistat
1.0 mg/mL in Acetonitrile
|
O-032
|
|
|
Aripiprazole-D8
100 ug/mL in Acetonitrile
|
A-081
|
|
|
Orlistat Related Compound D
100 ug/mL in Acetonitrile
|
O-033
|
|
|
Atorvastatin calcium salt
1.0 mg/mL (as free carboxylate) in Methanol
|
A-078
|
|
|
Over-The-Counter Multi-Component Mixture-6
100 ug/mL of each component in Acetonitrile
|
O-034
|
|
|
Atropine-D3
100 ug/mL in Acetonitrile
|
A-077
|
|
|
Oxymorphone-D3-3-β-D-glucuronide (Internal Standard)
100 ug/mL in 1:1 Methanol:Water
|
O-031
|
|
|
Buprenorphine-D4
1.0 mg/mL in Methanol
|
B-908
|
|
|
Paclitaxel
1.2 mg/mL in Acetonitrile
|
P-065
|
|
|
Caffeine Qualification Standards Kit for HPLC
Each ampoule at stated concentration (ug/mL) in Water
|
OQ-003
|
|
|
Pain Management Multi-Component Opiate Mixture-13
100 ug/mL of each component; 10 ug/mL of Fentanyl in Methanol
|
P-071
|
|
|
Caffeine Qualification Standards Kit for LC/MS
Each ampoule at stated concentration (ug/mL) in Water
|
OQ-002
|
|
|
Pheniramine-D6 maleate
100 ug/mL (as free base) in Methanol
|
P-062
|
|
|
Carbamazepine-D10
100 ug/mL in Methanol
|
C-094
|
|
|
Phentermine-D5 HCl
100 ug/mL (as free base) in Methanol
|
P-034
|
|
|
Citalopram HBr
1.0 mg/mL (as free base) in Methanol
|
C-095
|
|
|
Potassium Acid Phthalate Aqueous Carbon-1000
1000 ug/mL (ppm Carbon) in Water
|
ERP-129
|
|
|
Citalopram-D6 HBr
100 ug/mL (as free base) in Methanol
|
C-090
|
|
|
Potassium Acid Phthalate Aqueous Carbon-2000
2000 ug/mL (ppm Carbon) in Water
|
ERP-130
|
|
|
Clenbuterol-D9 HCl
100 ug/mL (as free base) in Methanol
|
C-081
|
|
|
Pregabalin-D6
100 ug/mL in Methanol
|
P-072
|
|
|
Clonazepam-D4
1.0 mg/mL in Methanol
|
C-906
|
|
|
Progesterone
1.0 mg/mL in Acetonitrile
|
P-069
|
|
|
Clopidogrel carboxylic acid HCl
100 ug/mL (as free base) in Methanol
|
C-092
|
|
|
Progesterone-D9
100 ug/mL in Acetonitrile
|
P-070
|
|
|
Clozapine-D4
100 ug/mL in Methanol
|
C-091
|
|
|
Propofol
1.0 mg/mL in Methanol
|
P-076
|
|
|
Codeine-6-β-D-glucuronide
100 ug/mL in Water:Methanol (80:20)
|
C-087
|
|
|
Propofol-D17
100 ug/mL in Methanol
|
P-077
|
|
|
Cyclosporin A
1.0 mg/mL in Acetonitrile
|
C-093
|
|
|
Quetiapine-D8 hemifumarate
100 ug/mL (as free base) in Methanol
|
Q-002
|
|
|
D6-25-Hydroxyvitamin D3 (26,26,26,27,27,27-D6)
50 ug/mL in Ethanol
|
H-074
|
|
|
Rebaudioside A
1.0 mg/mL in 50:50 (ACN:Water)
|
S-016
|
|
|
N-Desmethylcitalopram HCl
1.0 mg/mL (as free base) in Methanol
|
D-047
|
|
|
Rebaudioside A Impurities Mix-6
100 ug/mL of each component in 50:50 (ACN:Water)
|
S-017
|
|
|
Diethylpropion HCl
1.0 mg/mL (as free base) in Methanol
|
D-050
|
|
|
Residual Solvents Class 2 - Mixture A
Each component at stated concentration (mg/mL) in DMSO
|
R-007
|
|
|
Disopyramide
1.0 mg/mL in Methanol
|
D-054
|
|
|
Residual Solvents Class 2 - Mixture B
Each component at stated concentration (ug/mL) in DMSO
|
R-008
|
|
|
EDDP-D3 perchlorate
1.0 mg/mL (as pyrrolinium) in Methanol
|
E-062
|
|
|
Residual Solvents Class 2 - Mixture C
Each component at stated concentration (mg/mL) in DMSO
|
R-009
|
|
|
Ethosuximide
1.0 mg/mL in Methanol
|
E-067
|
|
|
Residual Solvents Mixture Class 1
Each component at stated concentration (mg/mL) in DMSO
|
R-010
|
|
|
Ethyl sulfate sodium salt
1.0 mg/mL (as ethyl sulfate) in Methanol
|
E-064
|
|
|
Salicylic acid
1.0 mg/mL in Acetonitrile
|
S-019
|
|
|
Ethyl-β-D-glucuronide
1.0 mg/mL in Methanol
|
E-015
|
|
|
Sirolimus (Rapamycin)
1.0 mg/mL in Acetonitrile
|
S-015
|
|
|
Ethyl-β-D-glucuronide-D5
1.0 mg/mL in Methanol
|
E-063
|
|
|
Sufentanil-D5
100 ug/mL in Methanol
|
S-018
|
|
|
Hydromorphone-D4
100 ug/mL in Methanol
|
H-078
|
|
|
Tacrolimus
1.0 mg/mL in Acetonitrile
|
T-049
|
|
|
Hydromorphone-D6
1.0 mg/mL in Methanol
|
H-050
|
|
|
Tapentadol HCl
1.0 mg/mL (as free base) in Methanol
|
T-058
|
|
|
α-Hydroxymidazolam
1.0 mg/mL in Methanol
|
H-922
|
|
|
Tapentadol-D3 HCl
100 ug/mL (as free base) in Methanol
|
T-059
|
|
|
iMethod™ Test Kit for Benzodiazepines
|
IMF-020
|
|
|
Temazepam glucuronide lithium salt
100 ug/mL (as free acid) in Methanol
|
T-050
|
|
|
iMethod™ Test Kit for Benzodiazepines with Synthetic Urine
|
IMF-020S
|
|
|
Tox Screen Internal Standard Mix-3
Each component at stated concentration (mg/L) in Methanol
|
T-052
|
|
|
iMethod™ Test Kit for NIDA 5 Drug Panel
|
IMF-021
|
|
|
Tox Screen Test Kit
|
T-062
|
|
|
iMethod™ Test Kit for NIDA 5 Drug Panel with Synthetic Urine
|
IMF-021S
|
|
|
Tox Screen Test Mix-9
Each component at stated concentration (mg/L) in Methanol
|
T-051
|
|
|
Levetiracetam-D6
100 ug/mL in Methanol
|
L-023
|
|
|
Tramadol-13C, D3 HCl
1.0 mg/mL (as free base) in Methanol
|
T-020
|
|
|
Levorphanol tartrate dihydrate
1.0 mg/mL (as free base) in Methanol
|
L-016
|
|
| |